Higher PIPP expression in breast cancer correlates with a better prognosis, defined as no development of distant metastases within 5 years of diagnosis, whereas lower PIPP mRNA expression predicts for reduced relapse-free and overall survival [105,114]. This evidence concerns the gene INPP5J and breast carcinoma.